AN ORGANIC ACID-INDUCED SIGMOIDAL RELEASE SYSTEM FOR ORAL CONTROLLED-RELEASE PREPARATIONS

被引:83
|
作者
NARISAWA, S [1 ]
NAGATA, M [1 ]
DANYOSHI, C [1 ]
YOSHINO, H [1 ]
MURATA, K [1 ]
HIRAKAWA, Y [1 ]
NODA, K [1 ]
机构
[1] TANABE SEIYAKU CO LTD,PHARMACEUT RES LAB,KASHIMA 3-CHOME,YODOGAWA KU,OSAKA 532,JAPAN
关键词
CONTROLLED RELEASE; ORGANIC ACID; RELEASE-ENHANCING; SIGMOIDAL RELEASE; LAG TIME; FILM COATING;
D O I
10.1023/A:1018910114436
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To achieve time-controlled or site-specific drug delivery in the gastrointestinal tract, a sigmoidal release system (SRS) was developed, which achieved a prolonged lag time, followed by rapid release. The theophylline beads with a thick Eudragit RS film coating showed very low drug release in water, whereas the release rate increased considerably in organic acid solutions. A hydration study of Eudragit RS films suggested that the increase in drug release was attributable to structural changes of the film induced by polymer-acid interactions. When succinic acid was incorporated into the core of Eudragit RS-coated theophylline beads, the drug release profile showed a typical sigmoidal pattern. SRS beads containing acetaminophen were also prepared by the same technique. Again, a sigmoidal release pattern was observed in which the lag time was prolonged with an increase in the coating level, whereas the drug release rate thereafter was almost constant irrespective of the coating level. Acetaminophen-containing SRS beads with different coating thickness were orally administered to beagle dogs. The drug plasma concentration curves showed lag periods similar to the in vitro lag time.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 50 条
  • [21] Formic Acid-Induced Controlled-Release Hydrolysis of Microalgae (Scenedesmus) to Lactic Acid over Sn-Beta Catalyst
    Zan, Yifan
    Sun, Yuanyuan
    Kong, Lingzhao
    Miao, Gai
    Bao, Liwei
    Wang, Hao
    Li, Shenggang
    Sun, Yuhan
    [J]. CHEMSUSCHEM, 2018, 11 (15) : 2492 - 2496
  • [22] ANALGESIC EFFICACY AND SAFETY OF 2 ORAL CONTROLLED-RELEASE MORPHINE PREPARATIONS IN ORTHOPEDIC POSTOPERATIVE PAIN
    COOPER, SA
    FITZMARTIN, R
    SLYWKA, J
    BUCKLEY, BJ
    KAIKO, R
    GOLDENHEIM, PD
    MOOAR, P
    WITTE, JF
    HERSH, EV
    [J]. ADVANCES IN THERAPY, 1994, 11 (05) : 213 - 227
  • [23] BIOAVAILABILITY OF CONTROLLED-RELEASE MESALAZINE (5-ASA) PREPARATIONS
    RASMUSSEN, SN
    [J]. JOURNAL OF GASTROENTEROLOGY, 1995, 30 : 112 - 114
  • [24] DISSOLUTION KINETICS OF COMMERCIALLY AVAILABLE CONTROLLED-RELEASE THEOPHYLLINE PREPARATIONS
    JALAL, I
    ZMAILY, E
    NAJIB, N
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 52 (01) : 63 - 70
  • [25] PAIN MANAGEMENT OF BORTEZOMIB-INDUCED NEUROPATHY WITH ORAL CONTROLLED-RELEASE OXYCODONE
    Cartoni, C.
    Brunetti, G. A.
    Niscola, P.
    Alfieri, P. L.
    Delia, G. M.
    Foa, R.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 49 - 49
  • [26] PHARMACOKINETICS OF ORAL CONTROLLED-RELEASE MORPHINE-SULFATE
    SAVARESE, JJ
    THOMAS, GB
    ROTHWELL, KG
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (06): : 460 - 460
  • [27] FORMULATION AND EVALUATION OF TERFENADINE MICROBALLOONS FOR ORAL CONTROLLED-RELEASE
    JAYANTHI, G
    JAYASWAL, SB
    SRIVASTAVA, AK
    [J]. PHARMAZIE, 1995, 50 (11): : 769 - 770
  • [28] Oral bioavailability of morphine from controlled-release formulations
    Dittrich, P
    Semmelrock, J
    Wolf, G
    Beubler, E
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1996, 108 (05) : 147 - 152
  • [29] DEVELOPMENT OF CONTROLLED-RELEASE FORMULATIONS OF KETOPROFEN FOR ORAL USE
    HABIB, MJ
    MESUE, R
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (12) : 1463 - 1472
  • [30] THE PROMISE AND LIMITATIONS OF CONTROLLED-RELEASE ORAL LEVODOPA ADMINISTRATION
    CEDARBAUM, JM
    [J]. CLINICAL NEUROPHARMACOLOGY, 1989, 12 (03) : 147 - 166